Summary
The effects of intravenous strophanthin K (0.125 and 0.25 mg) and lanatoside C (0.4, 0.8 and 1.6 mg) on systolic time intervals (STI) and impedance plethysmographic (IP) values were studied in ten patients with compensated coronary heart disease. The heart rate decreased significantly during a two-hour study in the lying position after both glycosides and placebo; the systemic blood pressure remained unchanged. Electromechanical systole (QS2), left ventricular ejection time (LVET) and preejection period (PEP), corrected for heart rate (QS2I, LVETI, PEPI), showed no change after placebo. The glycosides caused no change in LVETI. QS2I was significantly shortened only after lanatoside C 1.6 mg. PEPI and ICT were significantly shortened by both doses of strophanthin K and lanatoside C; the effects were dose-related. Taking into consideration the effects of cardiac glycosides on STI, use of the index ICT/QS1, the quotient of isovolumic contraction time and electromechanical delay, is proposed, because it showed quite sensitively the increase in myocardial contractility after digitalis. The effect of strophanthin K could be detected 10 minutes, and that of lanatoside C 30–40 minutes, after injection. The amplitude of the IP curve and the relative pulse volume showed positive and negative changes without any trend after administration of placebo or glycoside. The data suggests that the usual therapeutic doses of these cardiac glycosides do not cause significant changes in the peripheral circulation in patients with compensated coronary heart disease, but their action on STI is quite marked, showing a positive inotropic effect.
Similar content being viewed by others
References
Weissler, A.M., Gamel, W.G., Grode, H.E., Cohen, S., Schoenfeld, C.D.: The effect of digitalis on ventricular ejection in normal human subjects. Circulation29 721–729 (1964)
Weissler, A.M., Kamen, A.R., Bornstein, R.S., Schoenfeld, C.D., Cohen, S.: The effect of deslanoside on the duration of the phases of ventricular systole in man. Amer. J. Cardiol.15 153–161 (1965)
Weissler, A.M., Snyder, J.R., Schoenfeld, C.D., Cohen, S.: Assay of digitalis glycosides in man. Amer. J. Cardiol.17 768–780 (1966)
Kaindl, F., Polzer, K., Schufried, F.: Rheographie. Eine Methode zur Beurteilung peripherer Gefässe. Darmstadt: Dietrich Steinkopff Verlag 1959
Eninya, G.I., Smeltere, E.S.: Comparative characteristics of the action produced by Dibazol on the cerebral circulation. (In Russian). Soviet. Med.36 136–137 (1973)
Békés, M., Gulyas, A., Kusztos, D.: Clinical evaluation of longacting nitrite compounds on the basis of their pharmacodynamic action. V. Conf. Hung. Ther. Invest. Pharmacol., Budapest, 1969, pp 231–233
Weissler, A.M., Harris, W.S., Schoenfeld, C.D.: Bedside technics for the evaluation of ventricular function in man. Amer. J. Cardiol.23, 577–583 (1969)
Weissler, A.M.: Resting and exercise systolic intervals. Circulation46, 633 (1972)
Spidick, D.H., Kumar, S., Flessas, A.P., Sriratanaban, A.D., Sosler, G., Klints, R.V., Muench, H.: Relationship of paper speed to precision of pulse wave measurements: A multiple observer study of left ventricular ejection time. Aerospace Med.40, 707–709 (1969)
Polzer, K., Schufried, F.: Die physikalischen Untersuchungsmethoden peripherer Gefässe unter besonderer Berücksichtigung der Rheographie. Ärztl. Forsch.10, 366–369 (1960)
Schufried, F.: Rheographie. Ärztl. Forsch.15, 455–462 (1961)
Fraenkel, A.: Strophanthintherapie. Berlin: Julius Springer Verlag: 1933
Laurence, D.R.: Clinical pharmacology. 3rd ed., London: J.A. Churchill Ltd. 1966
Selden, R., Smith, R.W.: Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay. Circulation45, 1176–1182 (1972)
Ross, J. jr., Braunwald, E., Waldhausen, J.A.: Studies on digitalis. II. Extracardiac effects on venous return and on the capacity of the peripheral vascular bed. J. clin. Invest.39, 937–942 (1960)
Ross, J. jr., Waldhausen, J.A., Braunwald, E.: Studies on digitalis. I. Direct effects on peripheral vascular resistance. J. clin. Invest.39, 930–936 (1960)
Braunwald, E., Bloodwell, R.D., Goldberg, L.I., Morrow, A.G.: Studies on digitalis. IV. Observations in man on the effects of digitalis preparations on the contractility of the non-failing heart and on total vascular resistance. J. clin. Invest.40, 52–59 (1961)
Weissler, A.M., Schoenfeld, C.D.: Effect of digitalis on systolic time intervals in heart failure. Amer. J. med. Sci.259, 4–20 (1970)
Wilson, W.S., Tolbert, J.H., DiGiulio, W.: Plasma digitoxin levels and serial left ventricular ejection times after a digitalizing dose of digitoxin. Amer. J. Cardiol.26, 162–164 (1970)
Shaver, J.A., Kroetz, F.W., Leonard, J.J., Paley, H.W.: The effect of steady-state increases in systemic arterial pressure on the duration of left ventricular ejection time. J. clin. Invest.47, 217–230 (1968)
Hodges, M., Friesinger, G.C., Riggins, R.C., Dagenais, G.R.: Effects of intravenously administered digoxin on mild left ventricular failure in acute myocardial infarction in man. Amer. J. Cardiol.29, 749–756 (1972)
Levy, A.M., Leaman, D.M., Hanson, J.S.: Effects of digoxin on systolic time intervals of neonates and infants. Circulation46, 816–823 (1972)
Wallace, A.G., Mitchell, J.H., Skinner, N.S., Sarnoff, S.J.: Duration of the phases of left ventricular systole. Circulat. Res.12, 611–619 (1963)
Gábor, Gy.: A systole dynamikája a sziv ép és kóros állapotában. Doktori disszertáció, Budapest, 1965
Austin, T.W., Ahuja, S.P., Boughner, D.R.: Atraumatic study of left ventricular events following acute myocardial infarction. Amer. J. Cardiol.29, 745–748 (1972)
Sambhi, M.P.: The isometric period of contraction as a determinant of cardiac performance and digitalis action. Amer. J. Cardiol.6, 1042–1048 (1960)
Apor, P.: Adatok a nyugalmi, “normál” szivciklusértékek kérdéséhez. Magy. belorv. Arch.25, 134–140 (1972)
Aronow, W.S., Bowyer, A.F., Kaplan, M.A.: External isovolumic contraction times and left ventricular ejection time/external isovolumic contraction time ratios at rest and after exercise in coronary heart disease. Circulation43, 59–65 (1971)
Bodrogi, Gy., Kálmán, P., Kusztos, D.: Über die Rolle der Rheokardiographie bei der Bestimmung der einzelnen Herzphasen. Acta med. Acad. Sci. Hung.18, 189 (1962)
Jaeger, H., Gutmann, J., Ruhenstroth-Bauer, G.: Methodische Untersuchungen zur klinischen Anwendung der Direktrheographie. Klin. Wschr.50, 967 (1972)
Mullick, S.C., Wheeler, H.B., Songster, G.F.: Diagnosis of deep venous thrombosis by measurement of electrical impedance. Amer. J. Surg.119, 417 (1970)
Van de Water, J.M., Mount, B.E., Barela, J.R., Schuster, R., Laecock, F.S.: Monitoring the chest with impedance. Chest64, 597 (1973)
Brokaert, A., Godfraind, T.: The actions of ouabain on isolated arteries. Arch. int. Pharmacodyn.203, 393–395 (1973)
Bloor, C.M., Walker, D.E., Pensinger, R.R.: Ouabain induced primary coronary vasocontriction. Proc. Soc. exp. Biol. (N.Y.)140, 1409–1413 (1972)
Stark, J.J., Sanders, C.A., Powell, Wm.J., jr.: Neurally mediated and direct effects of acetylstrophanthidin on canine skeletal muscle vascular resistance. Circul. Res.30, 274–282 (1972)
Archer, L.T., Hinshaw, L.B.: Dose-response effects of cardiac glycosides on pooling and systemic and pulmonary haemodynamics. Canad. J. Physiol. Pharmacol.48, 533–541 (1970)
Solti, F., Iskum, M.: Effect of strophanthin on venous pressure and on venous tone. Acta med. Acad. Sci. hung.14, 397–403 (1959)
Mason, D.T., Braunwald, E.: Studies on digitalis. X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients in heart failure. J. clin. Invest.43, 532–543 (1964)
Glover, W.E., Hanna, M.J.D., Speden, R.N.: Actions of cardiac glycosides on the vessels of the forearm and hand. Cardiovasc. Res.1, 341–348 (1967)
Kumar, R., Hood, W.B., jr., Gilmour, D.P., Abelmann, W.H.: Effects of acetylstrophanthidin on cardiovascular function in intact, conscious dogs. J. Pharmacol. exp. Ther.180, 24–30 (1972)
Dresdale, D.T., Yuceoglu, Y.Z., Michtom, Schultz, M., Lunger, M.: Effects of lanatoside C on cardiovascular haemodynamics. Acute digitalizing doses in subjects with normal hearts and with heart disease without failure. Amer. J. Cardiol.4, 88–99 (1959)
Mason, D.T., Braunwald, E.: Studies on digitalis. IX. Effects of ouabain on the nonfailing human heart. J. clin. Invest.42, 1105–1111 (1963)
Gorsch, K., Klein, W.W., Leb, G., Pavek, P., Passath, A.: Hämodynamische Vergleichsuntersuchungen verschiedener Herzglykoside. Z. Kreisl.-Forsch.61, 577–587 (1972)
Ogilvie, R.I., Ruedy, J.: An educational program in digitalis therapy. J. Amer. med. Ass.222, 50–55 (1972)
Rubin, I.L., Arbeit, S.R., Gross, H.: Diuretics versus digitalis in the treatment of congestive heart failure. J. clin. Pharmacol.12, 121–122 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matos, L., Békés, M., Polák, G. et al. Comparative study of the cardiac and peripheral vascular effects of strophantin K and lanatoside C in coronary heart disease. Eur J Clin Pharmacol 9, 27–37 (1975). https://doi.org/10.1007/BF00613426
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00613426